Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prestige Consumer Healthcare (PBH) Consolidated Net Income: 2009-2025

Historic Consolidated Net Income for Prestige Consumer Healthcare (PBH) over the last 17 years, with Mar 2025 value amounting to $214.6 million.

  • Prestige Consumer Healthcare's Consolidated Net Income fell 22.37% to $42.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $200.8 million, marking a year-over-year decrease of 2.48%. This contributed to the annual value of $214.6 million for FY2025, which is 2.52% up from last year.
  • Latest data reveals that Prestige Consumer Healthcare reported Consolidated Net Income of $214.6 million as of FY2025, which was up 2.52% from $209.3 million recorded in FY2024.
  • Over the past 5 years, Prestige Consumer Healthcare's Consolidated Net Income peaked at $214.6 million during FY2025, and registered a low of -$82.3 million during FY2023.
  • Its 3-year average for Consolidated Net Income is $113.9 million, with a median of $209.3 million in 2024.
  • Its Consolidated Net Income has fluctuated over the past 5 years, first tumbled by 140.07% in 2023, then skyrocketed by 354.34% in 2024.
  • Over the past 5 years, Prestige Consumer Healthcare's Consolidated Net Income (Yearly) stood at $164.7 million in 2021, then grew by 24.71% to $205.4 million in 2022, then crashed by 140.07% to -$82.3 million in 2023, then soared by 354.34% to $209.3 million in 2024, then increased by 2.52% to $214.6 million in 2025.